These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9745990

  • 21. Slow continuous hemofiltration and slow continuous ultrafiltration.
    Paganini EP.
    ASAIO Trans; 1988; 34(1):63-6. PubMed ID: 3377916
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Biocompatibility and acute renal failure.
    Kanagasundaram NS, Sakiewicz PG, Liangos O, Paganini EP.
    Lancet; 2000 Jan 22; 355(9200):313. PubMed ID: 10675091
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Haemodialysis membranes.
    Kaplan AA.
    Lancet; 1994 Nov 12; 344(8933):1363. PubMed ID: 7968043
    [No Abstract] [Full Text] [Related]

  • 28. Biocompatibility and acute renal failure.
    Star RA, Kimmel PL.
    Lancet; 2000 Jan 22; 355(9200):314. PubMed ID: 10675092
    [No Abstract] [Full Text] [Related]

  • 29. Hemofiltration is not associated with increased mortality in children receiving extracorporeal membrane oxygenation.
    Lou S, MacLaren G, Paul E, Best D, Delzoppo C, Butt W.
    Pediatr Crit Care Med; 2015 Feb 22; 16(2):161-6. PubMed ID: 25560421
    [Abstract] [Full Text] [Related]

  • 30. Acute renal failure and membranes. Some medical and ethical questions.
    Schaefer K, von Herrath D.
    Int J Artif Organs; 1996 Mar 22; 19(3):145-6. PubMed ID: 8675356
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The role of dialyzer biocompatibility in acute renal failure.
    Vanholder R, De Vriese A, Lameire N.
    Blood Purif; 2000 Mar 22; 18(1):1-12. PubMed ID: 10686437
    [No Abstract] [Full Text] [Related]

  • 34. [Role of tumor necrosis factor in hemodiafiltration].
    Tetta C, Segoloni G, Fidelio T, Licata C, Sancipriano GP, Iacono G, Ragni R, Vercellone A.
    Minerva Urol Nefrol; 1991 Mar 22; 43(3):181-3. PubMed ID: 1817342
    [Abstract] [Full Text] [Related]

  • 35. Haemodialysis membranes.
    Mujais S, Ivanovich P.
    Lancet; 1994 Nov 12; 344(8933):1362; author reply 1363. PubMed ID: 7968042
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Underdosing continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury.
    Ricci Z, Romagnoli S.
    J Crit Care; 2011 Apr 12; 26(2):221; author reply 222. PubMed ID: 21376525
    [No Abstract] [Full Text] [Related]

  • 38. Delivered dose of continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury: a retrospective study.
    Nurmohamed SA, Koning MV, Vervloet MG, Groeneveld AB.
    J Crit Care; 2011 Apr 12; 26(2):213-20. PubMed ID: 21036524
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.